. "156570"^^ . . . . . . "1061928871"^^ . . . . . . . "4211737"^^ . "32787" . . . . . . "Arakawa's syndrome II"@en . . . . . "Arakawa's syndrome II is an autosomal dominant metabolic disorder that causes a deficiency of the enzyme tetrahydrofolate-methyltransferase; affected individuals cannot properly metabolize methylcobalamin, a type of Vitamin B12."@en . . . . "\u0421\u0438\u043D\u0434\u0440\u043E\u043C \u0410\u0440\u0430\u043A\u0430\u0432\u0430 II (\u0430\u043D\u0433\u043B. Arakawa's syndrome II; \u0442\u0430\u043A\u043E\u0436 \u0430\u043D\u0433\u043B. Methionine synthase deficiency, Tetrahydrofolate-methyltransferase deficiency syndrome, N5-methylhomocysteine transferase deficiency, \u0441\u0438\u043D\u0434\u0440\u043E\u043C \u0434\u0435\u0444\u0456\u0446\u0438\u0442\u0443 \u043C\u0435\u0442\u0456\u043E\u043D\u0456\u043D\u0441\u0438\u043D\u0442\u0430\u0437\u0438, \u0441\u0438\u043D\u0434\u0440\u043E\u043C \u0434\u0435\u0444\u0456\u0446\u0438\u0442\u0443 \u0442\u0435\u0442\u0440\u0430\u0433\u0456\u0434\u0440\u043E\u0444\u043E\u043B\u0430\u0442\u043C\u0435\u0442\u0438\u043B\u0442\u0440\u0430\u043D\u0441\u0444\u0435\u0440\u0430\u0437\u0438, \u0441\u0438\u043D\u0434\u0440\u043E\u043C \u0434\u0435\u0444\u0456\u0446\u0438\u0442\u0443 N5-\u043C\u0435\u0442\u0438\u043B\u0433\u043E\u043C\u043E\u0446\u0438\u0441\u0442\u0435\u0457\u043D\u0442\u0440\u0430\u043D\u0441\u0444\u0435\u0440\u0430\u0437\u0438) \u2014 \u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0438\u0439 \u0441\u0438\u043D\u0434\u0440\u043E\u043C, \u0430\u0443\u0442\u043E\u0441\u043E\u043C\u043D\u043E-\u0434\u043E\u043C\u0456\u043D\u0430\u043D\u0442\u043D\u0435 \u043F\u043E\u0440\u0443\u0448\u0435\u043D\u043D\u044F \u043E\u0431\u043C\u0456\u043D\u0443 \u0440\u0435\u0447\u043E\u0432\u0438\u043D, \u044F\u043A\u0435 \u0441\u043F\u0440\u0438\u0447\u0438\u043D\u044E\u0454 \u0434\u0435\u0444\u0456\u0446\u0438\u0442 \u0444\u0435\u0440\u043C\u0435\u043D\u0442\u0443 \u0442\u0435\u0442\u0440\u0430\u0433\u0456\u0434\u0440\u043E\u0444\u043E\u043B\u0430\u0442\u043C\u0435\u0442\u0438\u043B\u0442\u0440\u0430\u043D\u0441\u0444\u0435\u0440\u0430\u0437\u0438."@uk . . . . . . . . . . . . . . . . . . . . . . . . "\u0421\u0438\u043D\u0434\u0440\u043E\u043C \u0410\u0440\u0430\u043A\u0430\u0432\u0430 II (\u0430\u043D\u0433\u043B. Arakawa's syndrome II; \u0442\u0430\u043A\u043E\u0436 \u0430\u043D\u0433\u043B. Methionine synthase deficiency, Tetrahydrofolate-methyltransferase deficiency syndrome, N5-methylhomocysteine transferase deficiency, \u0441\u0438\u043D\u0434\u0440\u043E\u043C \u0434\u0435\u0444\u0456\u0446\u0438\u0442\u0443 \u043C\u0435\u0442\u0456\u043E\u043D\u0456\u043D\u0441\u0438\u043D\u0442\u0430\u0437\u0438, \u0441\u0438\u043D\u0434\u0440\u043E\u043C \u0434\u0435\u0444\u0456\u0446\u0438\u0442\u0443 \u0442\u0435\u0442\u0440\u0430\u0433\u0456\u0434\u0440\u043E\u0444\u043E\u043B\u0430\u0442\u043C\u0435\u0442\u0438\u043B\u0442\u0440\u0430\u043D\u0441\u0444\u0435\u0440\u0430\u0437\u0438, \u0441\u0438\u043D\u0434\u0440\u043E\u043C \u0434\u0435\u0444\u0456\u0446\u0438\u0442\u0443 N5-\u043C\u0435\u0442\u0438\u043B\u0433\u043E\u043C\u043E\u0446\u0438\u0441\u0442\u0435\u0457\u043D\u0442\u0440\u0430\u043D\u0441\u0444\u0435\u0440\u0430\u0437\u0438) \u2014 \u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0438\u0439 \u0441\u0438\u043D\u0434\u0440\u043E\u043C, \u0430\u0443\u0442\u043E\u0441\u043E\u043C\u043D\u043E-\u0434\u043E\u043C\u0456\u043D\u0430\u043D\u0442\u043D\u0435 \u043F\u043E\u0440\u0443\u0448\u0435\u043D\u043D\u044F \u043E\u0431\u043C\u0456\u043D\u0443 \u0440\u0435\u0447\u043E\u0432\u0438\u043D, \u044F\u043A\u0435 \u0441\u043F\u0440\u0438\u0447\u0438\u043D\u044E\u0454 \u0434\u0435\u0444\u0456\u0446\u0438\u0442 \u0444\u0435\u0440\u043C\u0435\u043D\u0442\u0443 \u0442\u0435\u0442\u0440\u0430\u0433\u0456\u0434\u0440\u043E\u0444\u043E\u043B\u0430\u0442\u043C\u0435\u0442\u0438\u043B\u0442\u0440\u0430\u043D\u0441\u0444\u0435\u0440\u0430\u0437\u0438."@uk . . . . . . "3239"^^ . . . . . . . . . . . "Arakawa's syndrome II is an autosomal dominant metabolic disorder that causes a deficiency of the enzyme tetrahydrofolate-methyltransferase; affected individuals cannot properly metabolize methylcobalamin, a type of Vitamin B12."@en . "Arakawa's syndrome II"@en . . . . "Niedob\u00F3r syntazy metioninowej, niedob\u00F3r metylotransferazy homocysteinowej, zesp\u00F3\u0142 Arakawy II (ang. methionine synthase deficiency, tetrahydrofolate-methyltransferase deficiency syndrome, N5-methylhomocysteine transferase deficiency, Arakawa syndrome II) to genetycznie uwarunkowana choroba metaboliczna wynikaj\u0105ca z niedoboru enzymu metylotransferazy homocysteinowej. Dotkni\u0119te ni\u0105 osoby nie mog\u0105 w\u0142a\u015Bciwie metabolizowa\u0107 metylokobalaminy, jednej z postaci witaminy B12."@pl . . . . "Methionine synthase deficiency, Tetrahydrofolate-methyltransferase deficiency syndrome, and N5-methylhomocysteine transferase deficiency."@en . "156570"^^ . . . . . . "Arakawa's syndrome II"@en . "32787"^^ . . . . . . . . "\u0421\u0438\u043D\u0434\u0440\u043E\u043C \u0410\u0440\u0430\u043A\u0430\u0432\u0430 II"@uk . . . "Niedob\u00F3r syntazy metioninowej, niedob\u00F3r metylotransferazy homocysteinowej, zesp\u00F3\u0142 Arakawy II (ang. methionine synthase deficiency, tetrahydrofolate-methyltransferase deficiency syndrome, N5-methylhomocysteine transferase deficiency, Arakawa syndrome II) to genetycznie uwarunkowana choroba metaboliczna wynikaj\u0105ca z niedoboru enzymu metylotransferazy homocysteinowej. Dotkni\u0119te ni\u0105 osoby nie mog\u0105 w\u0142a\u015Bciwie metabolizowa\u0107 metylokobalaminy, jednej z postaci witaminy B12."@pl . . "Niedob\u00F3r syntazy metioninowej"@pl . .